Clinical Trials
3 trialsNCT00113893 2013-11-07
SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.
Scios, Inc.
Phase 2 Completed
NCT00095680 2010-10-22
Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma
Scios, Inc.
Phase 2 Completed
NCT00087867 2010-10-18
Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma
Scios, Inc.
Phase 2 Completed